270193 VO Pharmaceutical and solution chemistry of (metallo)drugs (2019S)
Labels
Registration/Deregistration
Note: The time of your registration within the registration period has no effect on the allocation of places (no first come, first served).
Details
Language: English
Examination dates
Lecturers
Classes (iCal) - next class is marked with N
- Tuesday 04.06. 15:00 - 17:00 Seminarraum 2 Währinger Straße 38 Dekanat 1. Stock
- Wednesday 05.06. 13:30 - 15:00 Hörsaal 4 Chemie HP Währinger Straße 42
- Friday 07.06. 09:00 - 11:00 Seminarraum 4 Institut Physikalische Chemie HP Währinger Straße 42
- Tuesday 18.06. 13:30 - 15:00 Hörsaal 4 Chemie HP Währinger Straße 42
- Wednesday 19.06. 10:00 - 12:00 Seminarraum 4 Institut Physikalische Chemie HP Währinger Straße 42
- Tuesday 25.06. 15:00 - 17:00 Seminarraum 2 Währinger Straße 38 Dekanat 1. Stock
- Wednesday 26.06. 14:00 - 16:00 Seminarraum 2 Währinger Straße 38 Dekanat 1. Stock
- Thursday 27.06. 09:00 - 11:00 Seminarraum 2 Währinger Straße 38 Dekanat 1. Stock
Information
Aims, contents and method of the course
Assessment and permitted materials
Minimum requirements and assessment criteria
Examination topics
Reading list
Medicinal Chemistry: Principles and Practice (Ed. F.D. King), Royal Society of Chemistry, 2002.; M.T. Beck; I. Nagypál; Chemistry of Complex Equilibria, Ellis Horwood, Chichester, UK, 1990; Metallotherapeutic Drugs and Metal-based Diagnostic Agents (Eds, M. Gielen, E.R.T. Tiekink), Wiley, Chichester, 2005.
Association in the course directory
EF-1, EF-2, EF-3
Last modified: Mo 07.09.2020 15:42
Factors affecting pharmacokinetics (LADME properties: liberation, absorption, distribution, metabolism, excretion), bioavailability, accumulation, biofluids; routes of drug administration. Acid-base properties: macroconstants and microscopic proton dissociation constants. Lipophilicity, solubility and their modifications. Experimental determination of pKa and logP values. Biological pH-buffers.
Metal containing drugs (anticancer/-bacterial/-diabetic; chelate therapy). Solution stability of metal complexes, complex formation equilibrium processes. Conditional stability constants. Concentration distribution. Experimental determination of stability constants. Lipophilicity of metal complexes. Redox properties of metal complexes.
Prodrugs (metallic, nonmetallic).
Effect of interaction with biological macromolecules (proteins, DNA) on pharmacokinetics. Plasma protein binding. Experimental determination of binding sites and binding constants of protein-ligand adducts.